glp-1 agonists vs bariatric surgery weight loss comparison vs. Drugs | Garnet Health | Mid-Hudson Healthcare System Metabolic surgery and GLP-1 agonists
Description
These strategies not only illustrate the depth and breadth of pharmaceutical research but also signify the frontier of future medical innovations
Nausea, vomiting, diarrhea, constipation, and abdominal pain were mainly transient and mild to moderate in severity
Recent insights into body composition changes, potential psychiatric effects, and perioperative risks highlight the importance of individualized care and ongoing monitoring
Optum Rx has also introduced a host of changes to ensure GLP-1 drugs are used responsibly, including optional utilization management (UM) and enhanced system edits
[DOI] [PubMed] [Google Scholar] 9.Killion EA, Wang J, Yie J, Shi SD, Bates D, Min X, et al
